Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 7/20 | 0.55 |
| ▸ | KDM1A | O60341 | 3/20 | 0.47 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2889346 | 0.88 | KCNA5 (0.44) | KCNA5RAB9A | |
| SCHEMBL2891657 | 0.87 | KCNA5 (0.44) | KCNA5RAB9AAR | |
| SCHEMBL2883678 | 0.85 | KCNA5 (0.46) | KCNA5GAA | |
| SCHEMBL2889515 | 0.84 | KCNA5 (0.43) | KCNA5ALDH1A1GAARAB9AMAPT | |
| SCHEMBL2887607 | 0.84 | KCNA5 (0.57) | KCNA5KDM1AMAOAALDH1A1GAA | |
| SCHEMBL2891262 | 0.82 | KCNA5 (0.43) | KCNA5ALDH1A1GAARAB9AMAPT | |
| SCHEMBL2887358 | 0.81 | KCNA5 (0.51) | KCNA5ALDH1A1MAPTAR | |
| SCHEMBL2883788 | 0.79 | KCNA5 (0.43) | KCNA5ALDH1A1GAARAB9AMAPT | |
| SCHEMBL2891148 | 0.79 | SMN1; SMN2 (0.48) | KCNA5MAOAALDH1A1RAB9AMAPT | |
| SCHEMBL2888950 | 0.78 | KCNA5 (0.42) | KCNA5ALDH1A1GAARAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7781483-B2 | Benzopyran compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-24 | — | — | US | disclosed |
| US-20070299130-A1 | Benzopyran Compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070299130-A1 | Benzopyran Compound | NR0B1, CYP2B6, RYR2 | KCNA5 69/4885KDM1A 2207/4885MAOA 1330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.